Cathie Wood Mops Up $8.1M Worth Of Zoom Stock After Q2 Earnings Beat, Sells Nvidia Shares In Excess Of $1M
Cathie Wood-led Ark Invest made significant trades on Tuesday, including a noteworthy move involving Zoom Video Communications (NASDAQ:ZM) and Nvidia Corporation (NASDAQ:NVDA).
The Zoom trade took center stage, with Ark Invest purchasing $8.1 million worth of Zoom shares, based on Tuesday’s closing price of $65.83. Ark Invest purchased 122,831 shares of the company through ARK Innovation ETF (NYSE:ARKK) and ARK Next Generation Internet ETF (NYSE:ARKW).
This move comes on the heels of recent developments that have kept Zoom in the spotlight. The company reported a strong earnings beat in the second quarter, accompanied by robust EPS guidance and the introduction of new AI features. These announcements have contributed to renewed investor interest, driving the stock’s performance.
Additionally, Ark Invest sold $1.02 million worth of Nvidia shares on the same day, based on Tuesday’s closing price of $456.68. The trade was made through the Next Generation ETF. This decision comes amid various developments affecting Nvidia’s stock performance.
See Also: Cathie Wood’s Ark Losing Its Shine: Flagship Fund Sees $717M Exodus From Investors in a Year
Analysts have been closely watching the company’s earnings, anticipating positive outcomes that could impact the stock’s trajectory. Expectations are that the company’s recent earnings report could have a significant impact on the stock’s trajectory, analysts anticipate that positive outcomes from the earnings release might lead to a bullish sentiment among investors. This optimism could potentially quell bearish concerns and contribute to a more favorable market outlook for Nvidia.
Other Key Trades:
- Ark Invest purchased CRISPR Therapeutics AG (NASDAQ:CRSP) shares through ARK Genomic Revolution ETF (BATS:ARKG).
- Significant buying activity was observed in Adaptive Biotechnologies (NASDAQ:ADPT) shares through ARKG.
- Ark Invest added Recursion Pharmaceuticals (NASDAQ:RXRX) shares to its portfolio through ARKG.
- Investment was made in Intellia Therapeutics Inc. (NASDAQ:NTLA) shares through ARKG.
- Ark Invest sold Codexis Inc. (NASDAQ:CDXS) shares through ARKG.
- Phenomex Inc. (NASDAQ:CELL) shares were also sold through ARKG.
Read Next: Cathie Wood’s Ark Invest Continues to Sell Shopify Shares Amid Q2 Ripples
Engineered by Benzinga Neuro, Edited by Shivdeep Dhaliwal
The GPT-4-based Benzinga Neuro content generation system exploits the extensive Benzinga Ecosystem, including native data, APIs, and more to create comprehensive and timely stories for you. Learn more.